quantisnow
FeedTopReportsPricing
⌘K
Live feed
14:03:29·48d
INSIDERFiling
Kiora Pharmaceuticals Inc. logo

President and CEO Strem Brian M. covered exercise/tax liability with 238 shares, decreasing direct ownership by 0.52% to 45,865 units (SEC Form 4)

KPRX· Kiora Pharmaceuticals Inc.
Health Care
Original source

Companies

  • KPRX
    Kiora Pharmaceuticals Inc.
    Health Care

Recent analyst ratings

  • Jan 19UpdateMaxim Group$2.50

Related

  • SEC2d
    SEC Form D filed by Kiora Pharmaceuticals Inc.
  • SEC16d
    Kiora Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits
  • INSIDER21d
    SEC Form 4 filed by Tosca Melissa
  • INSIDER21d
    SEC Form 4 filed by Daniels Eric Joseph
  • INSIDER21d
    SEC Form 4 filed by Strem Brian M.
  • SEC21d
    Kiora Pharmaceuticals Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
  • SEC29d
    SEC Form S-8 filed by Kiora Pharmaceuticals Inc.
  • SEC29d
    Kiora Pharmaceuticals Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022